PRECISION OPTICS CORPORATION, INC. (POCI) Debt Components
- 2026-03-31: Long-term Debt, Current MaturitiesUSD $577.90K; Long-term Debt, Excluding Current MaturitiesUSD $855.78K; Long-term DebtUSD $1.48M; Long-Term Debt, Maturity, Year OneUSD $596.33K.
- 2025-12-31: Long-term Debt, Current MaturitiesUSD $577.90K; Long-term Debt, Excluding Current MaturitiesUSD $1.00M; Long-term DebtUSD $1.63M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-09-30: Long-term Debt, Current MaturitiesUSD $577.90K; Long-term Debt, Excluding Current MaturitiesUSD $1.14M; Long-term DebtUSD $1.78M; Long-Term Debt, Maturity, Year OneUSD (m).
- 2025-06-30: Long-term Debt, Current MaturitiesUSD $577.90K; Long-term Debt, Excluding Current MaturitiesUSD $1.29M; Long-term DebtUSD (m); Long-Term Debt, Maturity, Year OneUSD (m).
PRECISION OPTICS CORPORATION, INC. Debt Components
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Long-term Debt, Current Maturities USD | Long-term Debt, Excluding Current Maturities USD | Long-term Debt USD | Long-Term Debt, Maturity, Year One USD | Long-Term Debt, Maturity, Year Two USD | Long-Term Debt, Maturity, Year Three USD | Long-Term Debt, Maturity, Remainder of Fiscal Year USD | Debt Instrument, Unamortized Discount (Premium) and Debt Issuance Costs, Net USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Five USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Four USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Three USD | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal in Year Two USD | Long-term Debt and Capital Lease Obligations, Repayments of Principal in Next Twelve Months USD | Convertible Notes Payable, Current USD | Notes Payable to Bank, Current USD | Long-term Debt and Lease Obligation USD | Long-Term Debt, Maturity, Year Four USD | Line of Credit Facility, Interest Rate at Period End pure | Long-term Debt and Capital Lease Obligations, Maturities, Repayments of Principal after Year Five USD |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-03-31 | $577.90K | $855.78K | $1.48M | $596.33K | $596.33K | $141.09K | $149.08K | $49.16K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-12-31 | $577.90K | $1.00M | $1.63M | (m) | (m) | (m) | (m) | $53.76K | (m) | $141.09K | $596.33K | $596.33K | $298.17K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-09-30 | $577.90K | $1.14M | $1.78M | (m) | (m) | (m) | (m) | $58.37K | (m) | $141.09K | $596.33K | $596.33K | $447.25K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | $577.90K | $1.29M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-06-30 | (m) | (m) | $1.93M | (m) | (m) | (m) | (m) | $62.98K | (m) | $141.09K | $596.33K | $596.33K | $596.33K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2025-03-31 | $576.40K | $1.44M | $2.08M | (m) | (m) | (m) | (m) | $67.42K | $146.79K | $594.58K | $594.58K | $594.58K | $148.64K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-12-31 | $427.76K | $1.61M | $2.08M | (m) | (m) | (m) | (m) | $39.46K | $146.79K | $594.58K | $594.58K | $594.58K | $148.64K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-09-30 | $285.90K | $1.75M | $2.08M | (m) | (m) | (m) | (m) | $46.50K | $146.79K | $594.58K | $594.58K | $594.58K | $148.64K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | $276.93K | $1.90M | (m) | (m) | (m) | (m) | (m) | $33.54K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-06-30 | (m) | (m) | $2.21M | (m) | (m) | (m) | (m) | (m) | $140.69K | $594.58K | $594.58K | $594.58K | $285.10K | (m) | (m) | (m) | (m) | (m) | (m) |
| 2024-03-31 | $513.26K | $1.79M | $2.34M | (m) | (m) | (m) | (m) | $35.59K | $513.26K | $513.26K | $513.26K | $513.26K | $128.31K | (m) | (m) | (m) | (m) | (m) | $158.53K |
| 2023-12-31 | $513.26K | $1.92M | $2.47M | $513.26K | $513.26K | $513.26K | $256.63K | $37.63K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $513.26K | (m) | (m) |
| 2023-09-30 | $513.26K | $2.05M | $2.60M | $513.26K | $513.26K | $513.26K | $384.94K | $39.67K | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $513.26K | (m) | (m) |
| 2023-06-30 | $513.26K | $2.18M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2023-06-30 | (m) | (m) | $2.73M | (m) | (m) | (m) | (m) | $41.71K | $513.26K | $513.26K | $513.26K | $513.26K | $513.26K | (m) | (m) | (m) | (m) | (m) | $164.66K |
| 2023-03-31 | $371.43K | $1.68M | $2.07M | (m) | (m) | (m) | (m) | $20.74K | $371.43K | $371.43K | $371.43K | $371.43K | $92.86K | (m) | (m) | (m) | (m) | 9.50% | $495.24K |
| 2022-12-31 | $371.43K | $1.77M | $2.17M | (m) | (m) | (m) | (m) | $-21.67K | $371.43K | $371.43K | $371.43K | $371.43K | $186.72K | (m) | (m) | (m) | (m) | 9.00% | $495.24K |
| 2022-09-30 | $371.43K | $1.87M | $2.26M | (m) | (m) | (m) | (m) | $22.60K | $371.43K | $371.43K | $371.43K | $371.43K | $278.57K | (m) | (m) | (m) | (m) | 7.75% | $495.24K |
| 2022-06-30 | $367.71K | $1.96M | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2022-06-30 | (m) | (m) | $2.35M | (m) | (m) | (m) | (m) | $23.53K | $371.43K | $371.43K | $371.43K | $371.43K | $371.43K | (m) | (m) | (m) | (m) | (m) | $495.24K |
| 2022-03-31 | $367.71K | $2.05M | $2.45M | (m) | (m) | (m) | (m) | (m) | $371.43K | $371.43K | $371.43K | $371.43K | $92.86K | (m) | (m) | (m) | (m) | (m) | $866.66K |
| 2021-12-31 | $367.71K | $2.15M | $2.54M | (m) | (m) | (m) | (m) | (m) | $371.43K | $371.43K | $371.43K | $371.43K | $185.71K | (m) | (m) | (m) | (m) | (m) | $866.66K |
| 2021-06-30 | $0.00 | $0.00 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
| 2021-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2021-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2020-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $808.96K | (m) | (m) | (m) | (m) |
| 2020-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $808.96K | (m) | (m) | (m) | (m) |
| 2020-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $808.96K | (m) | (m) | (m) | (m) |
| 2019-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) |
| 2016-01-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $51.25K | (m) | (m) | (m) |
| 2013-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2012-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $0.00 | (m) | (m) | (m) | (m) | (m) |
| 2012-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $51.25K | (m) | (m) | (m) | (m) | (m) |
| 2012-03-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $68.82K | (m) | (m) | (m) | (m) | (m) |
| 2011-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $67.57K | (m) | (m) | (m) | (m) | (m) |
| 2011-09-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $795.83K | (m) | (m) | (m) | (m) | (m) |
| 2011-06-30 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $780.83K | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Outset Medical, Inc. (OM) | United States | $0.059B | -1.09 |
| QT IMAGING HOLDINGS, INC. (QTI) | United States | $0.037B | |
| Streamex Corp. (STEX) | United States | $0.089B | -0.19 |
| IRIDEX CORP (IRIX) | United States | $0.011B | |
| Nexalin Technology, Inc. (NXL) | United States | $0.094B | |
| ENDRA Life Sciences Inc. (NDRA) | United States | $0.009B | |
| Neuraxis, INC (NRXS) | United States | $0.097B | |
| Nuwellis, Inc. (NUWE) | United States | $0.003B | |
| electroCore, Inc. (ECOR) | United States | $0.102B | |
| Vivani Medical, Inc. (VANI) | United States | $0.111B |